Abstract
Background The online BeUpstandingTM program is an eight-week workplace-delivered intervention for desk-based workers to raise awareness of the benefits of sitting less and moving more and build a supportive culture for change. A workplace representative (the “champion”) delivers the program, which includes a workshop where teams collectively choose their sit less/move more strategies. A toolkit provides the champion with a step-by-step guide and associated resources to support program uptake, delivery, and evaluation. Here we report on the main findings from the Australian national implementation trial of BeUpstanding.
Methods Recruitment (12/06/2019 to 30/09/2021) was supported by five policy and practice partners, with desk-based work teams from across Australia targeted. Effectiveness was measured via a single arm, repeated-measures trial. Data were collected via online surveys, toolkit analytics, and telephone calls with champions. The RE-AIM framework guided evaluation, with adoption/reach (number and characteristics); effectiveness (primary: self-reported workplace sitting time); implementation (completion of core components; costs); and, maintenance intentions reported here. Linear mixed models, correcting for cluster, were used for effectiveness, with reach, adoption, implementation, and maintenance outcomes described.
Results Of the 1640 website users who signed-up to BeUpstanding during the recruitment period, 233 were eligible, 198 (85%) provided preliminary consent, and 118 (50.6%) champions consented and started the trial, with 94% (n=111 champions) completing. Trial participation was from across Australia and across industries, and reached 2,761 staff, with 2,248 participating in the staff survey(s): 65% female, 64% university educated; 16.9% from non-English speaking background. The program effectively changed workplace sitting (−38.5 [95%CI −46.0 to −28.7] minutes/8-hour workday) and all outcomes targeted by BeUpstanding (behaviours and culture), with small-to-moderate statistically-significant effects observed. All participating teams (n=94) completed at least 5/7 core steps; 72.4% completed all seven. Most champions spent $0 (72%) or >$0-$5 (10%) per team member; most (67/70 96%) intended to continue or repeat the program.
Conclusions BeUpstanding can be adopted and successfully implemented by a range of workplaces, reach a diversity of staff, and be effective at creating a supportive culture for teams of desk-based workers to sit less and move more. Learnings will inform optimisation of the program for longer-term sustainability.
Trial registration ACTRN12617000682347.
The trial was prospectively registered on the 12th May, 2017 (ACTRN12617000682347), prior to the soft launch of the program, with the last update on the 11th June, 2019 prior to the commencement of recruitment to the trial on the 12th June, 2019.
Competing Interest Statement
The BeUpstanding program does include consultancy options within the toolkit. All and any proceeds from consultancy activities return to the research to continue to develop the research program.
Clinical Trial
ACTRN12617000682347
Funding Statement
The BeUpstanding program was supported by funding from the Queensland Government Healthier. Happier. Workplaces program, Safe Work Australia, Comcare, and the National Health and Medical Research Council of Australia through a Partnership Project Grant (#1149936) conducted in partnership with Comcare, Safe Work Australia, the Queensland Office of Industrial Relations, VicHealth, and Healthier Workplace WA. GNH was supported by an MRFF-NHMRC Emerging Leadership Investigator Grant (#1193815). NHMRC had no role in the study in terms of the design, data collection, management, analysis and/or interpretation. SKM salary is supported by the Health and Wellbeing Centre for Research Innovation (HWCRI), co-funded by The University of Queensland and the Queensland Government through Health and Wellbeing Queensland.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Human Research Ethics Committee of The University of Queensland (protocol code #2016001743 on the 9th January 2017). All participants provided informed consent. No individual or personally identifiable information is reported.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The datasets generated and analysed during the current study are available from the corresponding author on reasonable request.
